Basic principles of physiologically-based pharmacokinetic (PBPK) modeling and its impact in streamlining the drug development process are reviewed.
Heidi J. Einolf
Advertisement
Heidi J. Einolf is director, modeling and simulation, pharmacokinetic sciences, Novartis.
Articles by Heidi J. Einolf
Advertisement
Latest Updated Articles
Enabling the Virtual Human Through Physiologically-based Pharmacokinetic ModelingPublished: March 16th 2021 | Updated:
Advertisement
Advertisement
